Skip to main content

Table 1 Patient and tumour characteristics

From: Clinical image quality perception and its relation to NECR measurements in PET

  Value
Number of patients 71
Pathologic lesion, n (%)  
 Yes 42 (59.2)
 No 29 (40.8)
Indication, n (%)  
 Primary staging 16 (22.5)
 Follow-up/re-staging 53 (74.6)
 Non-oncological (FUO and aortic aneurysm graft) 2 (2.8)
Tumour type, n  
 Lymphoma (NHL/HD) 18 (11/7)
 Lung cancer (proved/suspicious/incidental) 13 (10/2/1)
 Breast cancer 9
 Melanoma 7
 Renal cell 3
 Oesophagus, larynx, stomach 2
 Adrenal, anal, colon, fibrosarcoma, follicular thyroid, hypopharynx, nasopharynx, oropharynx, ovarian, paraganglioma, myeloid sarcoma, mesothelioma, rectal, SCC right upper arm 1
Under therapy, n (%)  
 Yes 13 (18.3)
 No 56 (78.9)
 N/A 2 (2.8)
  1. FUO, fever of unknown origin; NHL, non-Hodgkin lymphoma; HL, Hodgkin lymphoma; SCC, squamous-cell carcinoma; N/A, not applicable.